openPR Logo
Press release

14th International Conference and Exhibition on Pharmaceutical Formulations 2017

12-30-2016 09:35 AM CET | Health & Medicine

Press release from: Conferenceseries LLC

Formulation 2017 August 28-29, 2017 Brussels, Belgium. Formulation conference is a worthy platform for the researchers and many delegates to meet, interact and share their ideas in various aspects of Chemistry under one roof. This conference is a direct access to the renowned scientists, Professors and various pharma markets which make Belgium a perfect business location.
The conference will highlight on the production and manufacturing of drugs. The production of dosage forms should be increased with the increasing population.
This conference will create a perfect environment to share research experiences and can have presentations, Oral talks, Poster presentation and Exhibition.

Conference Series LLC organizes a conference series of 1000+ Global Events inclusive of 1000+ Conferences, 1000+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Sam Dexter | Program Manager
Formulations 2017
731 Gull Ave., Foster City │CA 94404, USA │Tel: +1-702-508-5200
formulations@pharmaceuticalconferences.org
conferenceseries.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 14th International Conference and Exhibition on Pharmaceutical Formulations 2017 here

News-ID: 403396 • Views:

More Releases for Formulation

Global Formulation Development Outsourcing Market Report Forecast to 2027
Global Formulation Development Outsourcing Market Formulation development can be outsourced to speed up the creation of possible APIs. Increased partnerships due to the availability of well-known people. Due to greater online collaborations, advancements in the field of information technology have pushed outsourcing even further. It has considerably shortened the time it takes to transfer information/technology in a secure, dependable, and confidential manner. The rising number of cases of new-born disorders, as
Abuse Deterrent Formulation Technologies Market 2020: Understand The Key Growth …
This report is an extensive analysis of current and potential trends in the Abuse Deterrent Formulation Technologies market. The report provides an in-depth quantitative analysis of the current and future market estimations which helps to recognize the prevailing market opportunities. Key market players within the market are profiled in this report and their strategies are analysed completely which help to understand the competitive outlook 2020-2024. Global Abuse Deterrent Formulation Technologies Market
Global Abuse-Deterrent Formulation Technologies Market is outperforming over Per …
Abuse-Deterrent Formulation Technology instant release opioids. It targets the acknowledged or probable routes of abuse, such as crushing in order to snort or dissolving in order to inject, for the specific opioid drug substance. The science of abuse deterrence is relatively new. Although the recent introduction to the market of extended-release (ER) opioid analgesics (re-)formulated with abuse-deterrent (AD) properties, prescription opioid abuse is an ongoing epidemic. Both the formulation technologies
Phosphatidylserine Market Estimation, Formulation, Validation and Segmentation B …
In 2018, the market size of Phosphatidylserine is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2018; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.In this report, 2017 has been considered as the base year and 2018 to 2025 as the
Chitodent® salicylate-free toothpaste homoeopathic formulation
Chitodent® is a homoeopathic toothpaste formulation without fluorine. Chitodent® salicylate-free toothpaste originated from a research contract with EUTEC. The active ingredient is chitosan. Many extensive global research studies have confirmed the effectiveness of chitosan, which does not have an allergenic effect. Chitosan is a real wonder drug for good teeth and healthy gums. Chitosan has an antibacterial effect on pathogens, plaque, caries and periodontal disease. Chitosan has a stimulating effect on wound healing. Chitosan
Global Biological Crop Protection Market Analysis and Forecast 2017-2022 by Appl …
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of global biological crop protection market on the basis of By Type (Biofungicide, Bioinsecticide and Bioherbicide), By Mode of Application (Dry Formulation and Wet Formulation), By End User (Fruit and Vegetables, Cereals and Pulses and Other Crops), By Region (North America, Europe, APAC and ROW),